Fosaprepitant for Injection, 150 mg / vial in a 10 mL Single-Dose vial, Rx only, Fresenius Kabi, Lake Zurich, IL 60047; NDC 63323-972-10
Published July 22, 2020 · Recall initiated: July 13, 2020
Summary
FDA records drug Class III recall D-1391-2020, published July 22, 2020 and initiated July 13, 2020. Recalling firm: Fresenius Kabi USA, LLC; Status: Terminated; Reported quantity: 63,067 vials; Lot: Lot #: 6122760, 6122761, exp 08/2021; 6122762, exp 09/2021; 6123883, exp 03/2022. Class III means the product is not likely to cause adverse health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Labeling Error: Label Error on Declared Strength: Carton label and product insert incorrectly states the quantity of the excipient edetate disodium (EDTA) as 5.4 mg / vial, rather than the actual amount of 18.8 mg / vial.
What to do
Voluntary: Firm initiated · Letter
Get an email if FOSAPREPITANT has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- FOSAPREPITANT
- Manufacturer
- Fresenius Kabi USA, LLC
- Distributor
- Nationwide within the United States
- UPC
- 0363323972103
- Lot
- Lot #: 6122760, 6122761, exp 08/2021; 6122762, exp 09/2021; 6123883, exp 03/2022
- Risk classification
- Class III
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAFosaprepitant for Injection 150 mg per vial, Sterile lyophilized powder for Intravenous use only afterJanuary 31, 2024
- FDALidothol Patch, Lidocaine 4.5% & Menthol 5%, In each patch: lidocaine 4.5% topical anesthetic, menthol 5%July 22, 2020
- FDAGarlic Shrimp Poke weighed and packed in plastic containers in the deli section per customer request. CookedJuly 22, 2020
- FDAAuryxia (ferric citrate) tablets 210 mg, Rx Only, 200 tablets per bottle, Manufactured for and distributed by:July 22, 2020
- FDASimilac Pro-Advance Infant Formula with Iron, Milk-Based, Ready to Feed, 32 FL OZ (1 QT)July 22, 2020
- FDAProparacaine Hydrochloride Ophthalmic Solution, USP, 0.5%, 15 mL per dropper bottle, Sterile, Rx Only,July 22, 2020
Questions about this recall
Was Fosaprepitant for Injection, 150 mg / vial in a 10 mL Single-Dose vial, Rx only, Fresenius Kabi, Lake Zurich, IL 60047; NDC 63323-972-10 recalled?
Yes. FDA published recall D-1391-2020 on July 22, 2020. Reported hazard: Labeling Error: Label Error on Declared Strength: Carton label and product insert incorrectly states the quantity of the excipient edetate disodium (EDTA) as 5.4 mg / vial, rather than the actual amount of 18.8 mg / vial.
What should I do if I have this product?
Voluntary: Firm initiated · Letter
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: FOSAPREPITANT. UPC: 0363323972103.